Showing results (181-190 of 290) with videos related to
Sort By:
Pageof 29
JCO Precision Oncology|September 3, 2021
Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or CholangiocarcinomaKarthikeyan Murugesan, Radwa Sharaf, Meagan Montesion, et al.JCO Precision Oncology|April 10, 2018
TMPRSS2-ERG fusions unexpectedly identified in men initially diagnosed with nonprostatic malignanciesPrimo N Lara, Andreas M Heilmann, Julia A Elvin, et al.JAMA Oncology|July 17, 2015
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted TherapiesJeffrey S Ross, Kai Wang, Laurie Gay, et al.International Journal of Cancer|August 29, 2015
The distribution of BRAF gene fusions in solid tumors and response to targeted therapyJeffrey S Ross, Kai Wang, Juliann Chmielecki, et al.Journal of Gastrointestinal Oncology|August 29, 2018
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibitionDavid A Fabrizio, Thomas J George, Richard F Dunne, et al.British Journal of Cancer|April 21, 2018
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinomaGuillermo de Velasco, Stephanie A Wankowicz, Russell Madison, et al.Breast Cancer Research and Treatment|February 18, 2017
Comprehensive genomic profiling of malignant phyllodes tumors of the breastSahar Nozad, Christine E Sheehan, Laurie M Gay, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2016
Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic TargetEvgeny Yakirevich, Murray B Resnick, Shamlal Mangray, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung CancerAlexa B Schrock, Allison Welsh, Jon H Chung, et al.Lung Cancer (Auckland, N.Z.)|May 6, 2020
Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase InhibitorsAlexa B Schrock, Russell Madison, Mark Rosenzweig, et al.Pageof 29